CHENGDU SHENGNUO BIOTEC CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.35 CNY | +0.07% |
|
-4.57% | -3.01% |
| May. 07 | Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection | MT |
| Apr. 22 | ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 597M 82.65M | Sales 2025 * | 784M 108M | Capitalization | 3.06B 424M |
|---|---|---|---|---|---|
| Net income 2024 * | 109M 15.09M | Net income 2025 * | 147M 20.35M | EV / Sales 2024 * | 5.13 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.91 x |
| P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
20.9
x | Employees | 1,128 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.25% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.07% | ||
| 1 week | -4.57% | ||
| Current month | -5.75% | ||
| 1 month | +1.30% | ||
| 3 months | +25.46% | ||
| 6 months | -6.30% | ||
| Current year | -3.01% |
1 week
27.10
29.02
1 month
25.5730.83
Current year
16.4632.30
1 year
16.4635.38
3 years
14.7657.86
5 years
14.7657.86
10 years
14.7657.86
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Jun Wen
CEO | Chief Executive Officer | 58 | 01-07-22 |
Li Wu
DFI | Director of Finance/CFO | 50 | 14-09-30 |
Jing Meng Zhang
ADM | Chief Administrative Officer | 43 | 06-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Qiong Tang
BRD | Director/Board Member | 61 | 18-12-11 |
Yong Jun Wen
CEO | Chief Executive Officer | 58 | 01-07-22 |
Fa Sheng Wen
BRD | Director/Board Member | 44 | 16-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 27.35 | +0.07% | 580,962 |
| 24-05-16 | 27.33 | -0.91% | 598,078 |
| 24-05-15 | 27.58 | -0.58% | 686,889 |
| 24-05-14 | 27.74 | +0.40% | 1,429,629 |
| 24-05-13 | 27.63 | -3.59% | 1,413,546 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes
Cheng Du Sheng Nuo Biotec Co Ltd is a China-based company mainly engaged in the research and development of peptide active pharmaceutical ingredients (APIs) and preparation products. The Company's products target areas including immunology, digestive tract, antivirus, gynecology, diabetes, cardio-cerebrovascular, rare diseases, orthopedics and other fields. The Company is also engaged in customized peptide production services for customers, customized production services for peptide APIs and preparations, and technology transfer services for peptide drug production. The Company also provides small-molecule chemical drug Levosimendan preparations on behalf of processing, Levosimendan bulk drug production and export sales business.
Sector
Pharmaceuticals
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
27.35
CNY
Average target price
38
CNY
Spread / Average Target
+38.94%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.01% | 424M | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
- Stock Market
- Equities
- 688117 Stock